Data gathered: November 13
Alternative Data for Clearmind Medicine Common Shares
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 94 | Sign up | Sign up | Sign up |
| Webpage traffic | 3,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,808 | Sign up | Sign up | Sign up |
| Twitter Mentions | 109 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Clearmind Medicine Common Shares
Clearmind Medicine Inc., a preclinical pharmaceutical company, develops new psychedelic drugs to treat neglected health problems. The company is headquartered in Vancouver, Canada.
| Price | $1.47 |
| Target Price | Sign up |
| Volume | 88,290 |
| Market Cap | $6.4M |
| Year Range | $1.02 - $2.22 |
| Dividend Yield | 0% |
| PE Ratio | 0.16 |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical SiteOctober 9 - Yahoo |
Clearmind announces IRB approval for FDA first-in-human trial of CMND-100October 9 - Thefly.com |
|
FDA is said to see “path forward” for ecstasy-based drugOctober 18 - Seeking Alpha |
|
Bright Minds rally ends as psychedelic stocks extend volatilityOctober 15 - Seeking Alpha |
|
Why Aehr Test Systems Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving PremarketOctober 10 - Benzinga |
|
Clearmind Medicine Files International Patent For Ibogaine Combination TherapySeptember 16 - Benzinga |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 0 | 15,000 | -15,000 | -2.1M | -810,000 | -0.588 |
| Q2 '24 | 0 | 0 | 0 | -910,000 | -1.7M | -0.279 |
| Q1 '24 | 0 | 0 | 0 | -1.4M | -1.5M | -0.901 |
| Q4 '23 | 0 | 5,500 | -5,500 | -4.1M | 660,000 | -11.439 |
| Q3 '23 | 0 | 4,000 | -4,000 | -3M | 480,000 | -2.434 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
Read more about Clearmind Medicine Common Shares (CMND) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of Clearmind Medicine Common Shares?
The Market Cap of Clearmind Medicine Common Shares is $6.4M.
What is Clearmind Medicine Common Shares' PE Ratio?
As of today, Clearmind Medicine Common Shares' PE (Price to Earnings) ratio is 0.16.
What is the current stock price of Clearmind Medicine Common Shares?
Currently, the price of one share of Clearmind Medicine Common Shares stock is $1.47.
How can I analyze the CMND stock price chart for investment decisions?
The CMND stock price chart above provides a comprehensive visual representation of Clearmind Medicine Common Shares' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Clearmind Medicine Common Shares shares. Our platform offers an up-to-date CMND stock price chart, along with technical data analysis and alternative data insights.
Does CMND offer dividends to its shareholders?
As of our latest update, Clearmind Medicine Common Shares (CMND) does not offer dividends to its shareholders. Investors interested in Clearmind Medicine Common Shares should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Clearmind Medicine Common Shares?
Some of the similar stocks of Clearmind Medicine Common Shares are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.